Modelling PK/QT relationships from Phase I dose-escalation trials for drug combinations and developing quantitative risk assessments of clinically relevant QT prolongations. [electronic resource]

By: Contributor(s): Producer: 20170717Description: 264-76 p. digitalISSN:
  • 1539-1612
Subject(s): Online resources: In: Pharmaceutical statistics vol. 15
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.